gentamicin has been researched along with imipenem, anhydrous in 171 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 50 (29.24) | 18.7374 |
| 1990's | 50 (29.24) | 18.2507 |
| 2000's | 30 (17.54) | 29.6817 |
| 2010's | 27 (15.79) | 24.3611 |
| 2020's | 14 (8.19) | 2.80 |
| Authors | Studies |
|---|---|
| Bareford, D; Bayston, KF; Bint, AJ; Cefai, C; Cohen, J; Leyland, MJ; Murray, SA; Newland, AC; Warren, R; White, DG | 1 |
| Andrews, JM; Cooper, MA; Wise, R | 1 |
| Andrade, R; Cabello, M; Clavijo, E; Lucena, M; Queipo de Llano, E | 1 |
| Giamarellou, H; Xirouchaki, E | 1 |
| Fukuda, H; Hashimoto, H; Hirai, K; Iyobe, S; Jakics, EB | 1 |
| Branger, T; Cornelissen, JJ; de Graeff, A; Dekker, AW; Rozenberg-Arska, M; Verdonck, LF; Verhoef, J | 1 |
| Watanakunakorn, C | 1 |
| Barrett, MS; Erwin, ME; Johnson, DM; Jones, RN | 1 |
| Milkovich, G; Piazza, CJ | 1 |
| Inoue, M; Iyobe, S; Mitsuhashi, S; Watanabe, M | 1 |
| Kumagai, K; Nishibuchi, M; Otsuki, H; Takeda, Y | 1 |
| Fuursted, K | 1 |
| Chin, NX; Neu, HC | 2 |
| Geshan, AE; Giardina, JA; Guzzo, J; Halstead, DC | 1 |
| Calame, W; Craig, WA; Ebert, S; Fantin, B; Leggett, JE; Mattie, H; Totsuka, K; Vogelman, B | 1 |
| Chin, NX; Neu, HC; Novelli, A | 2 |
| Archambaud, M; Clave, D; Labau, E; Suc, C | 1 |
| Lahnborg, G; Nord, CE | 2 |
| Morooka, T; Oda, T; Shigeoka, H | 1 |
| Bale, M; Howard, W; Koontz, F; Pfaller, M; Preston, T | 1 |
| Bauer, D; Spohr, M; Traub, WH | 1 |
| Bailer, R; Chu, DT; Fernandes, PB; Hanson, CW; Stamm, JM; Vojtko, C | 1 |
| Kim, KS | 2 |
| Eriksson, M; Norrby, SR; Ottosson, E | 1 |
| Barza, M; Davey, PG; Stuart, M | 1 |
| Stratton, CW; Tausk, F; Weeks, LS | 1 |
| Barza, M; Davey, P; Stuart, M | 1 |
| Hessen, MT; Levison, ME; Pitsakis, PG | 1 |
| Jonsson, M; Norrby, SR | 1 |
| Fernandez-Guerrero, M; Henry, N; Rouse, M; Wilson, W | 1 |
| Creger, RJ; Danziger, LH; Hau, T; Shwed, JA; Stellato, TA | 1 |
| Barza, M; Gorbach, SL; Hackford, AW; Reinhold, RB; Tally, FP | 1 |
| Berlioux, J; Daguet, GL; Mugnier, P; Pasteau, C; Ygout, JF | 1 |
| Chin, NX; Espinoza, AM; Neu, HC; Novelli, A | 1 |
| Johnson, E; Kennedy, RH; Leaper, DJ; Roberts, N; Sutton, A | 1 |
| Avery, D; Kennedy, R; Leaper, D; Leow, C; Thomas, W | 1 |
| Appleman, MD; Berne, TV; Chenella, FC; Gill, MA; Heseltine, PN; Leedom, JM; Yellin, AE | 1 |
| Alonso, JM; Guiyoule, A; Jupeau-Vessieres, AM; Philippon, AM; Scavizzi, MR | 1 |
| Klastersky, J; Van der Auwera, P; Van Laethem, Y | 1 |
| Eley, A; Greenwood, D; McLeod, KM | 1 |
| Breyer, S; Francesconi, M; Georgopoulos, A; Graninger, W; Leitha, T; Lenz, K | 1 |
| Gorbach, SL; Tally, FP | 1 |
| Alexander, JW; Fant, WK; Rivera, JO; Solomkin, JS | 1 |
| Benonisen, E; Dibb, WL; Digranes, A; Salveson, A | 1 |
| Andrew, JH; Dixson, S | 1 |
| Gilchrist, MJ; Spelhaug, DR; Washington, JA | 1 |
| Braveny, I; Elsser, R; Machka, K | 1 |
| Pranada, F; Pusztai-Markos, Z | 1 |
| Berkowitz, LB; Cummings, MC; Gombert, ME | 1 |
| Alford, RH | 1 |
| Baumgartner, JD; Glauser, MP | 1 |
| Geraci, JE; Indrelie, JA; Matsumoto, JY; Washington, JA; Wilson, WR | 1 |
| Cherubin, CE; Corrado, ML; Jhagroo, M; Moen, J; Shulman, M | 1 |
| Alford, RH; McGee, ZA; Michael, PR | 1 |
| Baltch, AL; Conroy, JV; Hammer, MC; Matzkowitz, AJ; Smith, RP; Sutphen, NT | 1 |
| Díez Enciso, M; Gutiérrez Altés, A; Mateos Lindemann, M | 1 |
| Tisone, JC; Watanakunakorn, C | 1 |
| Erlendsdóttir, H; Gottfredsson, M; Gudmundsson, A; Gudmundsson, S | 1 |
| Delia, S; Iona, E; Mascellino, MT; Mastroianni, CM; Ponzo, R | 1 |
| Lacey, SL; Want, SV | 1 |
| Allen, DM; Ang, PT; Au, E; Tow, A | 1 |
| Isbister, WH; Sanea, O | 1 |
| Matsui, S | 1 |
| Garcia, A; Martín-Luengo, F; Martínez, F; Valdés, M | 1 |
| Burghoffer, B; Delisle, F; Le Cunff, D; Lesage, D; Petit, JC; Richard, G | 1 |
| Andremont, A; Carbon, C; Massias, L; Montravers, P | 1 |
| Bowyer, GW; Cumberland, N | 1 |
| Clark, RB; Joyce, SE | 1 |
| Bonner, DP; Fung-Tomc, J; Kolek, B | 1 |
| Eppes, SC; Klein, JD | 1 |
| Evans, ME; Pollack, M | 1 |
| Dalhoff, A; Nitsche, D; Oesser, S; Sack, M; Schulze, C | 1 |
| Antony, SJ; Matherin, P; Stratton, C | 1 |
| Choi, YJ; Hong, T; Kish, A; Millett, W; Ndamukong, J; Win, KK | 1 |
| Deguchi, K; Fukayama, S; Ishihara, R; Koguchi, M; Oda, S; Suzuki, Y | 1 |
| Barclay, ML; Begg, EJ; Chambers, ST; Peddie, BA | 1 |
| Clevenbergh, P; De Gheldre, Y; De Ryck, R; Maes, N; Rost, F; Struelens, MJ; Vincent, JL | 1 |
| Flynn, CM; Johnson, DM; Jones, RN | 1 |
| Bossuyt, M; De Backer, T; Schoenaers, J | 1 |
| Iaconis, JP; Nadler, HL; Pitkin, DH; Sheikh, W | 1 |
| Bacci, S; Bosi, A; Fanci, R; Guidi, S; Laszlo, D; Rossi Ferrini, P; Saccardi, R; Vannucchi, AM | 1 |
| Hostacká, A | 1 |
| Dotters, DJ; James, AH; Katz, VL; Rogers, RG | 1 |
| Aleksandrova, IA; Grudinina, SA; Rezvan, SP; Sidorenko, SV; Sterkhova, GV | 1 |
| Blahová, J; Králiková, K; Krcméry, V; Mlynarcík, D; Trupl, J | 1 |
| Dionyssiou-Asteriou, A; Giamarellos-Bourboulis, EJ; Giamarellou, H; Grecka, P | 1 |
| Müller, P; Wertenbruch, R | 1 |
| Babini, GS; Bates, J; Livermore, DM; Palepou, MF; Woodford, N | 1 |
| Bolgos, G; Green, L; Newcomb, D; Remick, DG | 1 |
| Fukuhara, J; Furuhata, N; Ikeda, A; Kimura, F; Kouda, M; Maruyama, M; Matsuzaki, H; Nomura, H; Ohgawara, M; Ono, E; Sasaki, K; Satoh, H; Sawabe, E; Suzuki, T; Takahashi, I; Takeuchi, M; Tohi, H | 1 |
| Ball, S; Civetta, JM; Harvill, S; McKenney, MG; Namias, N; Salomone, JP; Sleeman, D | 1 |
| Lopez, SM; Rowen, JL | 1 |
| Igari, J; Nakamura, A; Oguri, T; Tabe, Y | 1 |
| Sato, S; Toriya, M; Tsuji, A; Yamaguchi, S | 1 |
| Hosino, K; Iwai, Y; Nakamura, A; Nakamura, S; O'Hara, K; Sawai, T; Seto, I | 1 |
| Minami, S; Ogake, N; Takahata, M; Yamashiro, Y | 1 |
| Asencio, MA; Blanco, J; Carro, J; Garduño, E; Pascasio, JM; Rebollo, M | 1 |
| Campo, C; Navarro, V; Salavert, M | 1 |
| Alter, P; Maisch, B; Schaefer, JR | 1 |
| Mazumder, A; Rahman, MU | 1 |
| Díez García, F; Gallego Rojo, FJ; Salas Coronas, J; Sánchez Sánchez, JC | 1 |
| Flores, C; Goldani, LZ; Hadlich, E; Maguilnik, I | 1 |
| Fedder, G; Heilmann, FG; Wong, PL | 1 |
| Amiot, DM; Buchman, TG; Coopersmith, CM; Davis, CG; Dunne, WM; Hotchkiss, RS; Husain, KD; Karl, IE; Osborne, DF; Stromberg, PE; Turnbull, IR | 1 |
| Deotale, V; Mendiratta, DK; Narang, P | 1 |
| Pruekprasert, P; Tunyapanit, W | 1 |
| Arakawa, S; Deguchi, T; Egashira, T; Fujime, M; Fujita, K; Fukuhara, Y; Furuya, N; Hirakata, Y; Hirose, T; Igari, J; Imafuku, Y; Ishibashi, K; Ishihara, S; Kamidono, S; Kitamura, M; Kobayashi, Y; Kohno, S; Kondo, A; Konishi, T; Kumamoto, Y; Kumon, H; Kunishima, Y; Matsuda, J; Matsuda, S; Matsukawa, M; Matsumoto, T; Monden, K; Murai, M; Muratani, T; Naito, S; Nakano, M; Oguri, T; Oka, T; Ooe, H; Sato, S; Shigeta, S; Suzutani, T; Tsukamoto, T; Uchida, H; Watanabe, K; Yamaguchi, K; Yamaguti, O; Yoshida, H | 1 |
| Bokaei, S; Etemadi, G; Feizabadi, MM; Rahmati, M; Shabanpoor, S; Yadegarinia, D | 1 |
| Gómez Gómez, J; López Fornás, F; Lorente Salinas, I; Martínez García, F; Pérez Salmerón, J; Roldán Conesa, D; Ruiz Gómez, J; Segovia Hernández, M; Valdés Chávarri, M | 1 |
| Buranapanitkit, B; Krisanapiboon, A; Oungbho, K | 1 |
| Antón-Aranda, E; Martí Cabané, J | 1 |
| Elsa, V; María, A; Nieves, B; Ruíz, J; Ruiz, M; Salazar De Vegas, EZ; Vila, J | 1 |
| Lartigue, MF; Nordmann, P; Poirel, L; Poyart, C; Réglier-Poupet, H | 1 |
| Bilewska, A; Luczak, M; Młynarczyk, A; Młynarczyk, G; Pupek, J | 1 |
| Laoprasopwattana, K; Laosombat, V; Pruekprasert, P; Wongchanchailert, M | 1 |
| Guo, ZL; He, LX; He, ZG; Liang, YJ; Ren, T; Zhai, XB; Zhang, L; Zheng, YH | 1 |
| Cha, R | 1 |
| Artini, M; Di Clemente, D; Palma, S; Papa, R; Scoarughi, GL; Selan, L; Veeh, R | 1 |
| Adukauskiene, D; Dambrauskiene, A; Jeroch, J; Vitkauskiene, A | 1 |
| Chen, Q; Hu, J; Hu, ZQ; Ke, XM; Ren, XQ; Yang, YM; Yu, SY; Zhou, W | 1 |
| Blázquez, J; López, E | 1 |
| Albertí, S; Juan, C; Mulet, X; Oliver, A; Pérez, JL; Zamorano, L | 1 |
| de Aguiar, HF; de Magalhães Lopes, CA; Duarte, MA; Martins, CH; Neto, DL; Weckwerth, AC; Weckwerth, PH | 1 |
| Lee, HJ; Lee, KM; Suh, JT; Yang, HY | 1 |
| Bajuk, M; Bombicino, K; De Ambrosio, A; Famiglietti, A; Gutkind, G; Nastro, M; Radice, M; Rodriguez, CH; Spinozzi, M; Vay, C | 1 |
| Eden, A; Le Falher, G; Le Moing, V; Lesnik, A; Makinson, A; Reynes, J | 1 |
| Altboum, Z; Kobiler, D; Levy, H; Ophir, Y; Pass, A; Rothschild, N; Schlomovitz, J; Tal, A; Weiss, S | 1 |
| Goto, H; Higaki, M; Honda, K; Ishii, H; Mikura, S; Nakamura, M; Okazaki, M; Tsunoda, T; Wada, H; Watanabe, T; Yasutake, T | 1 |
| Arai, K; Hatta, M; Hirakata, Y; Kaku, M; Kitagawa, M; Kunishima, H; Yano, H | 1 |
| Choi, M; Karp, NS; Levine, SM; Weichman, KE; Wilson, SC | 1 |
| Gandhi, RG; Leonard, SN; Patel, MD; Supple, ME | 1 |
| Haque, N; Hoque, SM; Hossain, MA; Kabir, MR; Paul, SK; Rahman, A; Sultana, S | 1 |
| Matar, GM; Nassar, FJ; Rahal, EA; Sabra, A | 1 |
| Crémieux, AC; Dinh, A; Hanachi, M; Le Dû, D; Roux, AL; Suy, F | 1 |
| Chen, CS; Chen, PL; Ko, WC; Tang, HJ; Tsai, PJ; Wu, CJ | 1 |
| Cardoso, O; Marques, M; Pereira, J; Pereira, SG | 1 |
| Baba, H; Horimoto, K; Kubo, T; Matsusaka, H; Umesue, M | 1 |
| Barthélémy, C; Chai, F; Debaene, B; Décaudin, B; Drouet, M; Lebuffe, G; Odou, P | 1 |
| Gholipourmalekabadi, M; Hashemi, A; Mozafari, M; Rostami, A; Sameni, M; Zamani, F | 1 |
| Aksaray, S; Avcıküçük, H; Başustaoğlu, A; Kaşkatepe, B; Süzük, S | 1 |
| Chen, TL; Chuang, MF; Huang, WC; Kuo, SC; Lauderdale, TL; Lee, Y; Tseng, KC; Yang, YS | 1 |
| Chen, Q; Cui, Y; Hu, Q; Li, W; Li, Y; Liu, Y; Shi, X; Sun, Q; Wu, Y; Zhang, Q | 1 |
| Ciszek, M; Dobrzaniecka, K; Grochowiecki, T; Grygiel, K; Młynarczyk, G; Pączek, L; Sańko-Resmer, J; Wilkowski, P; Łabuś, A | 1 |
| Dinic, M; Kocic, B; Mitic, R; Mladenovic-Antic, S; Petrovic, J; Randjelovic, G; Velickovic-Radovanovic, R | 1 |
| Cahan, A; Cohen, MJ; Kleinhendler, E; Moses, AE; Paltiel, O; Strahilevitz, J | 1 |
| Ambretti, S; Campoli, C; Gaibani, P; Giannella, M; Landini, MP; Lewis, RE; Re, MC; Viale, P; Volpe, SL | 1 |
| Azimi, L; Rastegar Lari, A | 1 |
| Alvarez, DN; Bayer, AS; Farah, S; Garcia-de-la-Maria, C; Miro, JM; Mishra, NN; Sakoulas, G; Zapata, B | 1 |
| Abdelwahab, SI; Dafalla, OME; Homeida, HE; Taha, MME | 1 |
| Gonçalves de Souza, T; Karine de Sousa, A; Melo Coutinho, HD; Ribeiro-Filho, J; Rocha, JE; Sampaio de Freitas, T | 1 |
| Charfi, S; Cherif, B; Hamden, K; Lassoued, S; Sahnoun, S; Sallemi, A; Triki, H | 1 |
| Mohapatra, PP; Padhi, L; Panda, SK; Sahoo, G | 1 |
| Haider Naqvi, SZ; Malik, A; Muddassir, M; Mumtaz, K; Munir, S; Raza, A; Shoaib Ahmed, S; Waqas, K | 1 |
| Li, S; Liu, W; Mo, Q; Shao, M; Sun, L; Ying, N; Zhu, L | 1 |
| Aiesh, BM; Alsayed, RB; Amer, R; Rabayah, R; Sabateen, A; Salameh, H; Taha, AA; Zyoud, SH | 1 |
| Chung, KK; DeLuca, JP; Kress, AT; Reed, T; Selig, DJ; Stewart, IJ | 1 |
| Ardebili, A; Bagheri, H; Goharrizi, MASB; Hjimohammadi, A; Izanloo, A; Jamali, A; Shahri, FN | 1 |
| Al Atbee, MYN; Jalil, MB | 1 |
| Ghorbani, G; Rahimi, E; Shakerian, A | 1 |
| Abbas Tikki, K; Hayder Hasan, T; Sabah Bustani, G; Sadeq Al-Ethari, A | 1 |
| Khan, M; Ma, K; Wan, I; Willcox, MD | 1 |
| Bond, GB; Chi, KD; Condas, LAZ; de Farias, MR; de Vargas, AC; Gonoi, T; Matsuzawa, T; Ribeiro, MG; Salerno, T; Siqueira, AK; Werner, J | 1 |
| Choi, HJ; Choi, JY; Choi, YH; Kim, C; Park, RW; Rhie, SJ | 1 |
| Maharjan, R; Nepali, R; Sigdel, B | 1 |
| Abdullah, FA; Abid, S; Albakeiri, TH; Ayesha, R; Aziz, T; Basit, Z; Falk, S; Ghani, M; Metab, A; Musarat, I; Nureen, Z; Yumna, F | 1 |
2 review(s) available for gentamicin and imipenem, anhydrous
| Article | Year |
|---|---|
Therapy of mixed anaerobic-aerobic infections. Lessons from studies of intra-abdominal sepsis.
Topics: Abdomen; Abscess; Bacteria, Anaerobic; Bacterial Infections; Bacteroides; Cilastatin; Clindamycin; Cyclopropanes; Drug Combinations; Gentamicins; Humans; Imipenem; Thienamycins | 1985 |
[Fournier's gangrene. A study of 12 patients and a review].
Topics: Administration, Topical; Adult; Aged; Cefotaxime; Clindamycin; Combined Modality Therapy; Comorbidity; Diabetes Mellitus; Drug Therapy, Combination; Fournier Gangrene; Gentamicins; Humans; Imipenem; Length of Stay; Male; Middle Aged; Penicillins; Povidone-Iodine; Scrotum; Sucrose; Surgery, Plastic | 2000 |
13 trial(s) available for gentamicin and imipenem, anhydrous
| Article | Year |
|---|---|
A comparative study of imipenem versus piperacillin plus gentamicin in the initial management of febrile neutropenic patients with haematological malignancies.
Topics: Adolescent; Adult; Aged; Drug Therapy, Combination; Fever; Gentamicins; Humans; Imipenem; Leukemia; Lymphoma; Middle Aged; Neutropenia; Piperacillin | 1992 |
Randomized multicenter clinical trial with imipenem/cilastatin versus cefotaxime/gentamicin in the treatment of patients with non-life-threatening infections. German and Austrian Imipenem/Cilastatin Study Group.
Topics: Adult; Aged; Aged, 80 and over; Bacterial Infections; Cefotaxime; Cilastatin; Drug Therapy, Combination; Female; Gentamicins; Humans; Imipenem; Male; Middle Aged | 1992 |
Imipenem versus gentamicin combined with either cefuroxime or cephalothin as initial therapy for febrile neutropenic patients.
Topics: Adult; Aged; Cefuroxime; Cephalothin; Drug Therapy, Combination; Female; Gentamicins; Humans; Imipenem; Injections, Intravenous; Male; Middle Aged; Neutropenia; Prospective Studies; Random Allocation | 1992 |
Imipenem/cilastatin versus gentamicin/clindamycin: a cost effectiveness study.
Topics: Cilastatin; Clindamycin; Clinical Trials as Topic; Cost-Benefit Analysis; Cyclopropanes; Drug Combinations; Drug Therapy, Combination; Gentamicins; Humans; Imipenem; Random Allocation; Thienamycins | 1986 |
Randomized trial of imipenem-cilastatin versus gentamicin plus clindamycin in the treatment of polymicrobial infections.
Topics: Adult; Aged; Bacteria; Bacterial Infections; Cilastatin; Cilastatin, Imipenem Drug Combination; Clindamycin; Drug Combinations; Drug Evaluation; Drug Therapy, Combination; Female; Gentamicins; Humans; Imipenem; Male; Middle Aged; Random Allocation | 1988 |
Prospective study comparing imipenem-cilastatin with clindamycin and gentamicin for the treatment of serious surgical infections.
Topics: Adolescent; Adult; Aged; Anti-Bacterial Agents; Bacteria, Aerobic; Bacteria, Anaerobic; Bacterial Infections; Cilastatin; Cilastatin, Imipenem Drug Combination; Clindamycin; Clinical Trials as Topic; Cyclopropanes; Drug Combinations; Drug Therapy, Combination; Female; Gentamicins; Humans; Imipenem; Male; Middle Aged; Prospective Studies; Random Allocation; Thienamycins | 1988 |
Treatment of acute bacterial peritonitis: a trial of imipenem/cilastatin against ampicillin-metronidazole-gentamicin.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Ampicillin; Anti-Bacterial Agents; Bacterial Infections; Cilastatin; Cilastatin, Imipenem Drug Combination; Clinical Trials as Topic; Cyclopropanes; Drug Combinations; Drug Therapy, Combination; Female; Gentamicins; Humans; Imipenem; Male; Metronidazole; Middle Aged; Peritonitis; Random Allocation; Thienamycins | 1987 |
Treatment of intra-abdominal infections using imipenem/cilastatin.
Topics: Aged; Ampicillin; Anti-Bacterial Agents; Bacterial Infections; Cilastatin; Cilastatin, Imipenem Drug Combination; Clinical Trials as Topic; Drug Combinations; Female; Gentamicins; Humans; Imipenem; Male; Metronidazole; Peritonitis | 1987 |
Randomized trial of imipenem/cilastatin versus gentamicin and clindamycin in mixed flora infections.
Topics: Adult; Aged; Bacterial Infections; Cilastatin; Clindamycin; Clinical Trials as Topic; Creatinine; Cyclopropanes; Drug Combinations; Female; Gentamicins; Humans; Imipenem; Male; Middle Aged; Random Allocation; Seizures; Thienamycins | 1985 |
Imipenem/cilastatin versus gentamicin/clindamycin for treatment of serious bacterial infections. Report from a Scandinavian Study Group.
Topics: Adolescent; Adult; Aged; Anti-Bacterial Agents; Bacterial Infections; Cilastatin; Clindamycin; Clinical Trials as Topic; Cyclopropanes; Drug Resistance, Microbial; Drug Therapy, Combination; Female; Gentamicins; Humans; Imipenem; Male; Middle Aged; Random Allocation; Thienamycins | 1984 |
Randomised study comparing imipenem/cilastatin to ceftriaxone plus gentamicin in cancer chemotherapy-induced neutropenic fever.
Topics: Antineoplastic Agents; Ceftriaxone; Cilastatin; Cilastatin, Imipenem Drug Combination; Costs and Cost Analysis; Drug Combinations; Drug Therapy, Combination; Female; Fever; Gentamicins; Humans; Imipenem; Male; Middle Aged; Neutropenia; Sepsis | 1994 |
Randomized trial comparing netilmicin plus imipenem-cilastatin versus netilmicin plus ceftazidime as empiric therapy for febrile neutropenic bone marrow transplant recipients.
Topics: Adolescent; Adult; Bacteria; Bacterial Infections; Bone Marrow Transplantation; Ceftazidime; Cephalosporins; Child; Cilastatin; Drug Synergism; Drug Therapy, Combination; Female; Fever; Gentamicins; Humans; Imipenem; Male; Middle Aged; Netilmicin; Neutropenia; Postoperative Complications; Protease Inhibitors; Thienamycins; Treatment Outcome | 1997 |
Clinical outcome of febrile neutropenia in children with cancer using ceftazidime and aminoglycosides.
Topics: Adolescent; Amikacin; Anti-Bacterial Agents; Bacteremia; Ceftazidime; Child; Child, Preschool; Disease-Free Survival; Female; Gentamicins; Guidelines as Topic; Humans; Imipenem; Infant; Male; Neoplasms; Neutropenia; Prospective Studies; Survival Rate | 2007 |
156 other study(ies) available for gentamicin and imipenem, anhydrous
| Article | Year |
|---|---|
In-vitro activity of PD 131628, a new quinolone antimicrobial agent.
Topics: Anti-Infective Agents; Bacteroides fragilis; Ceftazidime; Cefuroxime; Ciprofloxacin; Enterobacteriaceae; Fluoroquinolones; Gentamicins; Gram-Positive Bacteria; Haemophilus influenzae; Humans; Imipenem; Microbial Sensitivity Tests; Moraxella catarrhalis; Naphthyridines; Neisseria; Protein Binding; Quinolones | 1992 |
Imipenem/cilastatin-associated hiccups.
Topics: Anti-Bacterial Agents; Bacterial Infections; Cilastatin; Cilastatin, Imipenem Drug Combination; Drug Combinations; Gentamicins; Hiccup; Humans; Imipenem; Infusions, Intravenous; Male; Middle Aged; Tibial Fractures; Wound Infection | 1992 |
In vitro interactions of aminoglycosides with imipenem or ciprofloxacin against aminoglycoside resistant Acinetobacter baumannii.
Topics: Acinetobacter; Amikacin; Anti-Bacterial Agents; Ciprofloxacin; Drug Interactions; Drug Resistance, Microbial; Gentamicins; Humans; Imipenem; Microbial Sensitivity Tests; Netilmicin; Tobramycin | 1992 |
Occurrence of the nfxB type mutation in clinical isolates of Pseudomonas aeruginosa.
Topics: Carbenicillin; Chloramphenicol; Drug Resistance, Microbial; Genes, Bacterial; Gentamicins; Imipenem; Microbial Sensitivity Tests; Mutation; Norfloxacin; Phenotype; Plasmids; Pseudomonas aeruginosa; Transformation, Bacterial | 1992 |
Imipenem/gentamicin and imipenem/rifampin against methicillin-resistant Staphylococcus aureus.
Topics: Drug Resistance, Microbial; Drug Therapy, Combination; Gentamicins; Imipenem; Methicillin Resistance; Rifampin; Staphylococcus aureus | 1991 |
Antimicrobial activity of isepamicin (SCH21420, 1-N-HAPA gentamicin B) combinations with cefotaxime, ceftazidime, ceftriaxone, ciprofloxacin, imipenem, mezlocillin and piperacillin tested against gentamicin-resistant and susceptible gram-negative bacilli
Topics: Cefotaxime; Ceftazidime; Culture Media; Drug Interactions; Drug Resistance, Microbial; Drug Synergism; Drug Therapy, Combination; Enterobacteriaceae; Enterococcus; Gentamicins; Gram-Negative Bacteria; Imipenem; Mezlocillin; Piperacillin; Pseudomonas | 1991 |
Considerations in comparing intravenous and intramuscular antibiotics.
Topics: Anti-Bacterial Agents; Cefazolin; Cost Control; Costs and Cost Analysis; Gentamicins; Humans; Imipenem; Injections, Intramuscular; Injections, Intravenous; Penicillin G; Self Administration | 1991 |
Transferable imipenem resistance in Pseudomonas aeruginosa.
Topics: beta-Lactamases; Conjugation, Genetic; Drug Resistance, Microbial; Edetic Acid; Gentamicins; Hydrogen-Ion Concentration; Imipenem; Kinetics; Plasmids; Pseudomonas aeruginosa; Sulfonamides | 1991 |
[An in vitro study on combination effect of isepamicin and beta-lactam antibiotics].
Topics: Anti-Bacterial Agents; Cefoperazone; Cilastatin; Cilastatin, Imipenem Drug Combination; Drug Combinations; Drug Synergism; Drug Therapy, Combination; Gentamicins; Imipenem; Klebsiella pneumoniae; Microbial Sensitivity Tests; Moxalactam; Pseudomonas aeruginosa; Serratia marcescens | 1990 |
Further studies on post-antibiotic effect and synergism in two strains of Streptococcus faecalis.
Topics: Ampicillin; Drug Synergism; Enterococcus faecalis; Gentamicins; Imipenem; Microbial Sensitivity Tests; Netilmicin; Piperacillin; Streptomycin; Time Factors; Tobramycin; Vancomycin | 1989 |
In vitro activity of PD 117596-2, a broad-spectrum difluoroquinolone.
Topics: Anti-Infective Agents; Bacteria; Ceftazidime; Ciprofloxacin; Drug Resistance, Microbial; Enterobacteriaceae; Gentamicins; Imipenem; Microbial Sensitivity Tests; Ofloxacin; Pseudomonas; Staphylococcus; Streptococcus | 1989 |
In vitro bactericidal activities of gentamicin, cefazolin, and imipenem in peritoneal dialysis fluids.
Topics: Bacteria; Cefazolin; Dialysis Solutions; Gentamicins; Imipenem; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Staphylococcus aureus; Staphylococcus epidermidis; Time Factors | 1989 |
Comparative antibiotic dose-effect relations at several dosing intervals in murine pneumonitis and thigh-infection models.
Topics: Animals; Anti-Bacterial Agents; Cefazolin; Ceftazidime; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Gentamicins; Imipenem; Klebsiella Infections; Klebsiella pneumoniae; Lung; Mice; Mice, Inbred ICR; Muscles; Pneumonia | 1989 |
Comparative in vitro activity of a new quinolone, AM-1091.
Topics: 4-Quinolones; Anti-Infective Agents; Bacteria; Ceftazidime; Drug Resistance, Microbial; Fluoroquinolones; Gentamicins; Hydrogen-Ion Concentration; Imipenem; Microbial Sensitivity Tests; Mutation; Permeability | 1989 |
[Bactericidal effect of cefotaxime-sulbactam and imipenem combined with gentamicin and/or ciprofloxacin against CTX-1 producing Klebsiella pneumoniae].
Topics: Cefotaxime; Ciprofloxacin; Drug Synergism; Drug Therapy, Combination; Gentamicins; Imipenem; Klebsiella pneumoniae; Sulbactam | 1989 |
Efficacy of FCE 22101 compared with imipenem and with gentamicin plus metronidazole in the treatment of experimental intra-abdominal infections in rats.
Topics: Animals; Anti-Bacterial Agents; Bacteria; Bacterial Infections; Carbapenems; Gentamicins; Imipenem; Male; Metronidazole; Microbial Sensitivity Tests; Rats; Rats, Inbred Strains; Time Factors | 1989 |
In vitro evaluation of antibiotics for treatment of meningitis caused by Campylobacter fetus subspecies fetus.
Topics: Adult; Ampicillin; Anti-Bacterial Agents; Campylobacter fetus; Campylobacter Infections; Cephalosporins; Child, Preschool; Chloramphenicol; Gentamicins; Humans; Imipenem; Infant, Newborn; Meningitis; Microbial Sensitivity Tests; Middle Aged | 1989 |
In vitro inhibitory and bactericidal activity of cefpiramide and seven antipseudomonal agents against Pseudomonas aeruginosa.
Topics: Amikacin; Aminoglycosides; Anti-Bacterial Agents; Azlocillin; Cefoperazone; Cefsulodin; Ceftazidime; Cephalosporins; Drug Combinations; Drug Synergism; Gentamicins; Humans; Imipenem; Microbial Sensitivity Tests; Piperacillin; Pseudomonas aeruginosa; Thienamycins; Time Factors; Tobramycin | 1986 |
Streptococcus faecalis: in vitro susceptibility to antimicrobial drugs, single and combined, with and without defibrinated human blood.
Topics: Animals; Anti-Bacterial Agents; Blood; Cattle; Enterococcus faecalis; Fibrin; Fusidic Acid; Gentamicins; Humans; Imipenem; Microbial Sensitivity Tests; Ofloxacin; Oxazines; Penicillins; Rabbits; Thienamycins; Vancomycin | 1986 |
In vitro evaluation of A-56619 (difloxacin) and A-56620: new aryl-fluoroquinolones.
Topics: Anti-Infective Agents; Aztreonam; Bacteria; Cefotaxime; Ciprofloxacin; Drug Combinations; Enterobacteriaceae; Escherichia coli; Fluoroquinolones; Gentamicins; Haemophilus influenzae; Half-Life; Humans; Imipenem; Microbial Sensitivity Tests; Neisseria gonorrhoeae; Norfloxacin; Penicillins; Piperacillin; Piperazines; Pseudomonas aeruginosa; Quinolines; Staphylococcus aureus; Streptococcus; Thienamycins | 1986 |
In vitro and in vivo studies of imipenem-cilastatin alone and in combination with gentamicin against Listeria monocytogenes.
Topics: Ampicillin; Animals; Animals, Newborn; Cilastatin; Cyclopropanes; Drug Synergism; Drug Therapy, Combination; Gentamicins; Imipenem; Listeria monocytogenes; Listeriosis; Liver; Meningitis, Listeria; Rats; Sepsis; Spleen; Thienamycins | 1986 |
Dose response of experimental Pseudomonas endophthalmitis to ciprofloxacin, gentamicin, and imipenem: evidence for resistance to "late" treatment of infections.
Topics: Animals; Ciprofloxacin; Dose-Response Relationship, Drug; Endophthalmitis; Gentamicins; Imipenem; Pseudomonas aeruginosa; Pseudomonas Infections; Rabbits; Thienamycins; Time Factors; Vitreous Body | 1987 |
Beta-lactamase induction and aminoglycoside susceptibility in Pseudomonas aeruginosa.
Topics: Amikacin; Aminoglycosides; Anti-Bacterial Agents; beta-Lactamases; Drug Resistance, Microbial; Enzyme Induction; Gentamicins; Imipenem; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Thienamycins; Tobramycin | 1987 |
Tolerance of Pseudomonas aeruginosa to killing by ciprofloxacin, gentamicin and imipenem in vitro and in vivo.
Topics: Animals; Ciprofloxacin; Gentamicins; Imipenem; In Vitro Techniques; Male; Pseudomonas aeruginosa; Pseudomonas Infections; Rats; Rats, Inbred Strains; Thienamycins | 1988 |
Absence of a postantibiotic effect in experimental Pseudomonas endocarditis treated with imipenem, with or without gentamicin.
Topics: Animals; Aortic Valve; Disease Models, Animal; Drug Therapy, Combination; Endocarditis, Bacterial; Gentamicins; Heart Valve Diseases; Humans; Imipenem; Pseudomonas aeruginosa; Pseudomonas Infections; Rats; Rats, Inbred Strains; Thienamycins; Tricuspid Valve | 1988 |
Comparative in vitro activity of PD 127,391, a new fluorinated 4-quinolone derivative.
Topics: Anti-Infective Agents; Bacteria, Aerobic; Ceftazidime; Chemical Phenomena; Chemistry; Ciprofloxacin; Fluoroquinolones; Gentamicins; Gram-Negative Aerobic Bacteria; Humans; Imipenem; Microbial Sensitivity Tests; Pseudomonas aeruginosa | 1988 |
In vitro activity of E-1040, a novel cephalosporin with potent activity against Pseudomonas aeruginosa.
Topics: Aminoglycosides; beta-Lactamases; Cefepime; Cefpirome; Ceftazidime; Cephalosporins; Drug Resistance; Drug Stability; Gentamicins; Hydrolysis; Imipenem; Microbial Sensitivity Tests; Pseudomonas aeruginosa | 1988 |
Ciprofloxacin therapy of experimental endocarditis caused by methicillin-susceptible or methicillin-resistant Staphylococcus aureus.
Topics: Animals; Ciprofloxacin; Drug Therapy, Combination; Endocarditis, Bacterial; Gentamicins; Humans; Imipenem; Methicillin; Nafcillin; Penicillin Resistance; Rabbits; Staphylococcal Infections; Staphylococcus aureus; Thienamycins; Vancomycin | 1988 |
[Phenotypes of resistance to antibiotics of Acinetobacter baumannii. Impact on therapeutic orientation].
Topics: Acinetobacter; Acinetobacter Infections; Amikacin; Anti-Bacterial Agents; Drug Resistance, Microbial; Gentamicins; Humans; Imipenem; Norfloxacin; Pefloxacin; Phenotype; Thienamycins | 1988 |
Comparative in vitro activity of a new fluorinated 4-quinolone, T-3262 (A-60969).
Topics: Anti-Bacterial Agents; Bacteria; Ceftazidime; Ciprofloxacin; Fluoroquinolones; Gentamicins; Humans; Imipenem; Naphthyridines; Ofloxacin; Oxazines; Thienamycins | 1988 |
Imipenem therapy for perforated and gangrenous appendicitis.
Topics: Adult; Aged; Appendectomy; Appendicitis; Ascitic Fluid; Cilastatin; Clindamycin; Cyclopropanes; Drug Resistance, Microbial; Drug Therapy, Combination; Fever; Gangrene; Gentamicins; Humans; Imipenem; Intestinal Perforation; Length of Stay; Middle Aged; Rupture, Spontaneous; Thienamycins | 1986 |
Failure of newer beta-lactam antibiotics for murine Yersinia enterocolitica infection.
Topics: Amoxicillin; Animals; Cefotaxime; Doxycycline; Drug Evaluation, Preclinical; Gentamicins; Imipenem; Mice; Penicillin Resistance; Thienamycins; Yersinia enterocolitica; Yersinia Infections | 1987 |
Bactericidal activity and killing rate of serum against gram-positive cocci in volunteers receiving imipenem, oxacillin, vancomycin or ampicillin plus gentamicin.
Topics: Adult; Ampicillin; Blood Bactericidal Activity; Gentamicins; Gram-Positive Bacteria; Humans; Imipenem; Oxacillin; Penicillin Resistance; Staphylococcus; Streptococcus; Thienamycins; Vancomycin | 1987 |
Comparative in vitro activity and beta-lactamase stability of CGP 31523A, a new aminothiazolyl cephalosporin.
Topics: Aztreonam; Bacteria; beta-Lactamase Inhibitors; beta-Lactamases; Carbenicillin; Cefotaxime; Ceftazidime; Cephalosporins; Gentamicins; Humans; Imipenem; Microbial Sensitivity Tests; Penicillin Resistance; Thienamycins | 1986 |
Gentamicin assay in the presence of imipenem.
Topics: Drug Resistance, Microbial; Escherichia coli; Gentamicins; Imipenem; Thienamycins | 1986 |
Methicillin- and gentamicin-resistant Staphylococcus aureus: susceptibility to fosfomycin, cefamandole, N-formimidoyl-thienamycin, clindamycin, fusidic acid and vancomycin.
Topics: Cefamandole; Clindamycin; Fosfomycin; Fusidic Acid; Gentamicins; Imipenem; Methicillin; Microbial Sensitivity Tests; Penicillin Resistance; Staphylococcus aureus; Thienamycins; Vancomycin | 1985 |
Comparison of cefotaxime, imipenem-cilastatin, ampicillin-gentamicin, and ampicillin-chloramphenicol in the treatment of experimental Escherichia coli bacteremia and meningitis.
Topics: Ampicillin; Animals; Animals, Newborn; Cefotaxime; Chloramphenicol; Cilastatin; Cyclopropanes; Dose-Response Relationship, Drug; Drug Therapy, Combination; Escherichia coli Infections; Gentamicins; Imipenem; Meningitis; Rats; Sepsis; Thienamycins | 1985 |
Ro 17-2301: in vitro comparison with aztreonam, imipenem, ceftazidime, cefotaxime and netilmicin.
Topics: Acinetobacter; Anti-Bacterial Agents; Aztreonam; Ceftazidime; Enterobacteriaceae; Gentamicins; Imipenem; Microbial Sensitivity Tests; Netilmicin; Pseudomonas aeruginosa; Thienamycins | 1985 |
The in vitro activity of the newer beta-lactam antibiotics against 124 strains of gram-negative bacilli.
Topics: Anti-Bacterial Agents; Azlocillin; Aztreonam; Cephalosporins; Enterobacteriaceae; Gentamicins; Imipenem; Microbial Sensitivity Tests; Moxalactam; Piperacillin; Pseudomonas aeruginosa; Thienamycins; Ticarcillin | 1985 |
Bactericidal activity of antibiotics against Campylobacter fetus subspecies intestinalis.
Topics: Ampicillin; Campylobacter; Campylobacter fetus; Cefoperazone; Cefotaxime; Cephalosporins; Cephalothin; Cephamycins; Gentamicins; Imipenem; Lactams; Microbial Sensitivity Tests; Moxalactam; Streptomycin | 1981 |
Antibacterial activity of N-formimidoyl thienamycin in comparison with cefotaxime, lamoxactam, cefoperazone, piperacillin gentamicin.
Topics: Anti-Bacterial Agents; Bacteria; Cefoperazone; Cefotaxime; Cephalosporins; Cephamycins; Gentamicins; Imipenem; Lactams; Microbial Sensitivity Tests; Moxalactam; Penicillins; Piperacillin | 1982 |
In vitro activity of N-formimidoyl-thienamycin in comparison to that of moxalactam and cefotaxime against gentamicin-resistant gram-negative bacteria.
Topics: Acinetobacter; Bacteria; Cefotaxime; Cephalosporins; Cephamycins; Cross Infection; Drug Resistance, Microbial; Enterobacter; Escherichia coli; Gentamicins; Imipenem; Klebsiella; Microbial Sensitivity Tests; Moxalactam; Pseudomonas aeruginosa; Serratia; Thienamycins | 1982 |
Synergistic effect of N-formimidoyl thienamycin with gentamicin and amikacin against Streptococcus faecalis.
Topics: Amikacin; Anti-Bacterial Agents; Drug Synergism; Enterococcus faecalis; Gentamicins; Imipenem; Kanamycin; Microbial Sensitivity Tests; Thienamycins | 1983 |
Comparison of ceftazidime and N-formimidoyl thienamycin against gentamicin-susceptible and resistant Pseudomonas aeruginosa.
Topics: Anti-Bacterial Agents; Ceftazidime; Cephalosporins; Drug Resistance, Microbial; Gentamicins; Imipenem; Pseudomonas aeruginosa; Thienamycins | 1983 |
Comparative imipenem treatment of Staphylococcus aureus endocarditis in the rat.
Topics: Animals; Cloxacillin; Drug Therapy, Combination; Endocarditis, Bacterial; Female; Gentamicins; Imipenem; Rats; Rats, Inbred Strains; Staphylococcal Infections; Thienamycins; Time Factors | 1983 |
Synergy of imipenem or penicillin G and aminoglycosides against enterococci isolated from patients with infective endocarditis.
Topics: Aminoglycosides; Anti-Bacterial Agents; Drug Synergism; Drug Therapy, Combination; Endocarditis, Bacterial; Gentamicins; Humans; Imipenem; Microbial Sensitivity Tests; Penicillin G; Penicillin Resistance; Streptococcus; Streptomycin; Thienamycins | 1984 |
The activity of gentamicin and N-formimidoyl thienamycin (MK 0787) on Pseudomonas aeruginosa at pH 7.4 and 7.0.
Topics: Anti-Bacterial Agents; Gentamicins; Humans; Hydrogen-Ion Concentration; Imipenem; Lactams; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Pseudomonas Infections | 1981 |
Superior activity of N-formimidoyl thienamycin against gentamicin-resistant Pseudomonas aeruginosa.
Topics: Anti-Bacterial Agents; Drug Resistance, Microbial; Gentamicins; Imipenem; Lactams; Microbial Sensitivity Tests; Pseudomonas aeruginosa | 1981 |
In vitro comparison of N-formimidoyl thienamycin (MK0787) and Azlocillin with three aminoglycosides and ticarcillin against Pseudomonas aeruginosa.
Topics: Amikacin; Aminoglycosides; Anti-Bacterial Agents; Azlocillin; Gentamicins; Imipenem; Lactams; Microbial Sensitivity Tests; Penicillins; Pseudomonas aeruginosa; Ticarcillin; Tobramycin | 1982 |
In vitro evaluation of N-formimidoyl thienamycin (MK0787) combined with amikacin against gram-negative bacilli and Staphylococcus aureus.
Topics: Amikacin; Anti-Bacterial Agents; Bacteria; Drug Resistance, Microbial; Drug Synergism; Enterobacteriaceae; Gentamicins; Imipenem; Kanamycin; Pseudomonas aeruginosa; Staphylococcus aureus; Thienamycins | 1982 |
Synergism between N-formimidoyl thienamycin and gentamicin or tobramycin against enterococci.
Topics: Anti-Bacterial Agents; Drug Synergism; Enterococcus faecalis; Gentamicins; Imipenem; Microbial Sensitivity Tests; Streptococcus; Thienamycins; Time Factors; Tobramycin | 1982 |
Efficacy of piperacillin/tazobactam in the treatment of experimental intra-abdominal infections.
Topics: Abdomen; Animals; Bacterial Infections; beta-Lactamase Inhibitors; Clindamycin; Drug Therapy, Combination; Gentamicins; Imipenem; Male; Microbial Sensitivity Tests; Penicillanic Acid; Piperacillin; Rats; Rats, Sprague-Dawley; Tazobactam | 1994 |
Different patterns of bacterial DNA synthesis during postantibiotic effect.
Topics: Anti-Bacterial Agents; Ciprofloxacin; Dicloxacillin; DNA, Bacterial; Escherichia coli; Gentamicins; Imipenem; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Rifampin; Staphylococcus aureus; Tobramycin; Vancomycin | 1995 |
Infections due to Rhodococcus equi in three HIV-infected patients: microbiological findings and antibiotic susceptibility.
Topics: Actinomycetales Infections; Adult; AIDS-Related Opportunistic Infections; Anti-Bacterial Agents; Azithromycin; Bacteremia; Bronchoalveolar Lavage Fluid; Clarithromycin; Drug Resistance, Microbial; Drug Synergism; Drug Therapy, Combination; Erythromycin; Female; Gentamicins; HIV Infections; Humans; Imipenem; Male; Pleurisy; Pneumonia, Bacterial; Rhodococcus equi; Rifampin; Sputum; Teicoplanin; Vancomycin | 1994 |
An outbreak of Enterobacter cloacae associated with contamination of a blood gas machine.
Topics: Anti-Bacterial Agents; Bacteremia; Bacterial Typing Techniques; Blood Gas Analysis; Cross Infection; Disease Outbreaks; Enterobacter cloacae; Enterobacteriaceae Infections; Equipment Contamination; Gentamicins; Humans; Imipenem; Infant; Infant, Newborn; Infection Control; Thienamycins | 1995 |
Psoas abscess following ileo-anal pouch surgery.
Topics: Adult; Colitis, Ulcerative; Drug Therapy, Combination; Enterobacteriaceae Infections; Escherichia coli Infections; Gentamicins; Humans; Imipenem; Male; Proctocolectomy, Restorative; Psoas Abscess | 1995 |
[A case of severe pneumonia in an elderly man, caused by Citrobacter freundii suspected to have a low susceptibility to imipenem/cilastatin sodium].
Topics: Aged; Aged, 80 and over; Cilastatin; Cilastatin, Imipenem Drug Combination; Citrobacter freundii; Drug Combinations; Drug Resistance, Microbial; Drug Therapy, Combination; Enterobacteriaceae Infections; Gentamicins; Humans; Imipenem; Male; Pneumonia, Bacterial | 1994 |
Treatment with imipenem of experimental endocarditis caused by penicillin-resistant Streptococcus sanguis.
Topics: Animals; Disease Models, Animal; Drug Therapy, Combination; Endocarditis, Bacterial; Gentamicins; Imipenem; Microbial Sensitivity Tests; Penicillin Resistance; Rabbits; Streptococcal Infections; Streptococcus sanguis | 1994 |
Comparison of two techniques for measurement of in vitro killing kinetics of five antibiotics against Pseudomonas aeruginosa.
Topics: Amikacin; Anti-Bacterial Agents; Bacteriological Techniques; Ciprofloxacin; Gentamicins; Imipenem; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Ticarcillin | 1994 |
Investigation of the potential role of Enterococcus faecalis in the pathophysiology of experimental peritonitis.
Topics: Abscess; Amoxicillin; Animals; Anti-Bacterial Agents; Bacteremia; Bacteroides fragilis; Bacteroides Infections; Body Weight; Disease Models, Animal; Drug Synergism; Enterococcus faecalis; Escherichia coli; Escherichia coli Infections; Gentamicins; Gram-Positive Bacterial Infections; Imipenem; Male; Microbial Sensitivity Tests; Ornidazole; Pefloxacin; Peritoneum; Peritonitis; Rats; Rats, Sprague-Dawley; Specific Pathogen-Free Organisms | 1994 |
Antibiotic release from impregnated pellets and beads.
Topics: Amoxicillin; Anti-Bacterial Agents; Biological Assay; Calcium Sulfate; Ciprofloxacin; Drug Carriers; Floxacillin; Gentamicins; Imipenem; In Vitro Techniques; Methylmethacrylates; Penicillin G | 1994 |
Activity of meropenem and other antimicrobial agents against uncommon gram-negative organisms.
Topics: Anti-Bacterial Agents; Ceftriaxone; Gentamicins; Gram-Negative Bacteria; Imipenem; Meropenem; Microbial Sensitivity Tests; Penicillins; Thienamycins | 1993 |
Ciprofloxacin-induced, low-level resistance to structurally unrelated antibiotics in Pseudomonas aeruginosa and methicillin-resistant Staphylococcus aureus.
Topics: Amikacin; Cefepime; Cephalosporins; Ciprofloxacin; Drug Resistance, Microbial; Fusidic Acid; Gentamicins; Imipenem; Methicillin Resistance; Microbial Sensitivity Tests; Mutation; Pseudomonas aeruginosa; Staphylococcus aureus | 1993 |
Ochrobactrum anthropi bacteremia in a child.
Topics: Bacteremia; Ceftazidime; Child; Drug Therapy, Combination; Female; Gentamicins; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Imipenem; Microbial Sensitivity Tests; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Vancomycin | 1993 |
Effect of antibiotic class and concentration on the release of lipopolysaccharide from Escherichia coli.
Topics: Anti-Bacterial Agents; Ceftazidime; Ciprofloxacin; Electrophoresis, Polyacrylamide Gel; Escherichia coli; Gentamicins; Imipenem; Immunoblotting; Lipopolysaccharides; Polymyxin B; Tetracycline | 1993 |
Impact of different classes antimicrobial agents on plasma endotoxin activity.
Topics: Animals; Anti-Bacterial Agents; Anti-Infective Agents; Bacteremia; Blood Pressure; Cefotaxime; Cephalosporins; Ciprofloxacin; Colony Count, Microbial; Disease Models, Animal; Endotoxins; Escherichia coli; Escherichia coli Infections; Gentamicins; Imipenem; Male; Peritoneal Diseases; Peritoneum; Rats; Rats, Wistar; Thienamycins | 1996 |
Increased bactericidal activity as documented by serum bactericidal titers for a triple combination of cell wall active agents against gentamicin-resistant enterococci.
Topics: Adult; Ampicillin; Anti-Bacterial Agents; Bacteremia; Drug Resistance, Microbial; Drug Therapy, Combination; Enterococcus faecalis; Female; Gentamicins; Gram-Positive Bacterial Infections; Humans; Imipenem; Penicillins; Serum Bactericidal Test; Thienamycins; Vancomycin | 1995 |
Direct application of Etest to gram-positive cocci from blood cultures: quick and reliable minimum inhibitory concentration data.
Topics: Anti-Bacterial Agents; Blood; Cefotaxime; Cephalosporins; Culture Media; Erythromycin; Gentamicins; Gram-Positive Cocci; Imipenem; Microbial Sensitivity Tests; Penicillin G; Penicillins; Thienamycins; Vancomycin | 1996 |
[Antibacterial activities of combination uses of cefpirome with various antibiotics in vitro against clinically isolated glucose non-fermentative gram-negative rods: part 1. the results against Pseudomonas aeruginosa].
Topics: Amikacin; Anti-Bacterial Agents; Aztreonam; Cefpirome; Cephalosporins; Drug Combinations; Drug Synergism; Gentamicins; Imipenem; Piperacillin; Pseudomonas aeruginosa; Tobramycin | 1996 |
The effect of aminoglycoside-induced adaptive resistance on the antibacterial activity of other antibiotics against Pseudomonas aeruginosa in vitro.
Topics: Anti-Bacterial Agents; Aztreonam; Ceftazidime; Ciprofloxacin; Colony Count, Microbial; Drug Resistance, Microbial; Gentamicins; Imipenem; Piperacillin; Pseudomonas aeruginosa; Rifampin | 1996 |
Molecular epidemiology of an outbreak of multidrug-resistant Enterobacter aerogenes infections and in vivo emergence of imipenem resistance.
Topics: Anti-Bacterial Agents; Bacterial Typing Techniques; Disease Outbreaks; Drug Resistance, Multiple; Enterobacter; Enterobacteriaceae Infections; Female; Gentamicins; Humans; Imipenem; Male | 1997 |
In vitro efficacy of levofloxacin alone or in combination tested against multi-resistant Pseudomonas aeruginosa strains.
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Aztreonam; Ceftazidime; Ciprofloxacin; Drug Resistance, Multiple; Gentamicins; Humans; Imipenem; Levofloxacin; Microbial Sensitivity Tests; Ofloxacin; Piperacillin; Pseudomonas aeruginosa; Tobramycin | 1996 |
Management of necrotizing fasciitis in the neck.
Topics: Adult; Anti-Bacterial Agents; Anti-Infective Agents; Cilastatin; Combined Modality Therapy; Debridement; Drug Therapy, Combination; Fasciitis, Necrotizing; Focal Infection, Dental; Gentamicins; Humans; Hyperbaric Oxygenation; Imipenem; Male; Metronidazole; Neck; Penicillins; Protease Inhibitors; Thienamycins | 1996 |
Comparison of antibacterial activities of meropenem and six other antimicrobials against Pseudomonas aeruginosa isolates from North American studies and clinical trials.
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Bacterial Proteins; beta-Lactamases; Ceftazidime; Cephalosporins; Ciprofloxacin; Clinical Trials as Topic; Drug Resistance, Microbial; Gentamicins; Humans; Imipenem; Isoelectric Focusing; Meropenem; Microbial Sensitivity Tests; Penicillins; Piperacillin; Pseudomonas aeruginosa; Thienamycins; Tobramycin | 1997 |
Comparison of postantibiotic effects of imipenem and netilmicin alone and in combination against Pseudomonas aeruginosa.
Topics: Carbapenems; Drug Therapy, Combination; Gentamicins; Humans; Imipenem; Microbial Sensitivity Tests; Netilmicin; Pseudomonas aeruginosa; Pseudomonas Infections; Urinary Tract Infections | 1997 |
Clostridium difficile infection in obstetric and gynecologic patients.
Topics: Abdominal Pain; Adult; Aged; Aged, 80 and over; Ampicillin; Anti-Bacterial Agents; Bacterial Toxins; Cefoxitin; Cephalexin; Cephalosporins; Cephamycins; Ciprofloxacin; Clindamycin; Clostridioides difficile; Colonoscopy; Diarrhea; Enterocolitis, Pseudomembranous; Female; Fever; Gentamicins; Humans; Imipenem; Incidence; Middle Aged; Nausea; Penicillins; Pregnancy; Pregnancy Complications, Infectious; Retrospective Studies; Thienamycins; Trimethoprim, Sulfamethoxazole Drug Combination; Vomiting | 1997 |
[Comparative activity of meropenem and other antibiotics against the pathogens of nosocomial infections].
Topics: Anti-Bacterial Agents; Cephalosporins; Cross Infection; Drug Therapy, Combination; Gentamicins; Gram-Negative Bacteria; Gram-Positive Bacteria; Imipenem; Meropenem; Microbial Sensitivity Tests; Thienamycins; Tobramycin | 1998 |
Transduction of antibiotic resistance including imipenem resistance by wild type phages from nosocomial strains of Pseudomonas aeruginosa.
Topics: Anti-Bacterial Agents; Carbenicillin; Cross Infection; Drug Resistance, Microbial; Drug Resistance, Multiple; Gentamicins; Humans; Imipenem; Penicillin Resistance; Penicillins; Pseudomonas aeruginosa; Pseudomonas Infections; Pseudomonas Phages; Thienamycins; Transduction, Genetic | 1997 |
In vitro activity of polyunsaturated fatty acids on Pseudomonas aeruginosa: relationship to lipid peroxidation.
Topics: Amikacin; Ampicillin Resistance; Anti-Bacterial Agents; Arachidonic Acid; Ceftazidime; Cephalosporin Resistance; Cephalosporins; Colony Count, Microbial; Drug Resistance, Microbial; Drug Resistance, Multiple; Fatty Acids, Unsaturated; gamma-Linolenic Acid; Gentamicins; Imipenem; Lipid Peroxidation; Malondialdehyde; Microbial Sensitivity Tests; Penicillin Resistance; Penicillins; Piperacillin; Pseudomonas aeruginosa; Species Specificity; Thienamycins; Ticarcillin; Tobramycin; Vitamin E | 1998 |
[Right-heart endocarditis after pacemaker implantation as a cause of a round pulmonary infiltrate].
Topics: Anti-Bacterial Agents; Drug Therapy, Combination; Echocardiography, Transesophageal; Endocarditis, Bacterial; Follow-Up Studies; Gentamicins; Humans; Imipenem; Male; Middle Aged; Pacemaker, Artificial; Radiography, Thoracic; Sepsis; Staphylococcal Infections; Teicoplanin; Thienamycins; Time Factors | 1998 |
Carbapenemase-producing Pseudomonas aeruginosa in UK.
Topics: Amikacin; Anti-Bacterial Agents; Anti-Infective Agents; Bacterial Proteins; beta-Lactam Resistance; beta-Lactamase Inhibitors; beta-Lactamases; Carbapenems; Ceftazidime; Ciprofloxacin; Drug Resistance, Microbial; Enzyme Inhibitors; Gentamicins; Humans; Imipenem; Meropenem; Metalloproteins; Penicillanic Acid; Penicillins; Piperacillin; Pseudomonas aeruginosa; Tazobactam; Thienamycins; United Kingdom | 1998 |
Antibiotic treatment influences outcome in murine sepsis: mediators of increased morbidity.
Topics: Animals; Anti-Bacterial Agents; Body Temperature; Cecum; Ciprofloxacin; Clindamycin; Cytokines; Drug Therapy, Combination; Gentamicins; Imipenem; Interleukin-1; Interleukin-6; Lung; Mice; Mice, Inbred BALB C; Morbidity; Neutrophils; Peroxidase; Sepsis; Survival Rate; Tumor Necrosis Factor-alpha | 1998 |
[Evaluation of antibacterial activities of various antibiotics against glucose non-fermentative gram-negative rods other than Pseudomonas aeruginosa].
Topics: Anti-Bacterial Agents; Cefoperazone; Cephalosporins; Drug Resistance, Microbial; Drug Therapy, Combination; Gentamicins; Gram-Negative Aerobic Rods and Cocci; Humans; Imipenem; Minocycline; Penicillin Resistance; Penicillins; Piperacillin; Sulbactam; Thienamycins | 1998 |
Empiric therapy of sepsis in the surgical intensive care unit with broad-spectrum antibiotics for 72 hours does not lead to the emergence of resistant bacteria.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Critical Care; Drug Resistance, Microbial; Drug Therapy, Combination; Empiricism; Female; Gentamicins; Humans; Imipenem; Male; Microbial Sensitivity Tests; Middle Aged; Prospective Studies; Sepsis; Thienamycins; Time Factors | 1998 |
Morganella morganii early onset sepsis.
Topics: Adult; Ampicillin Resistance; Bacteremia; Cefotaxime; Cilastatin; Cilastatin, Imipenem Drug Combination; Drug Administration Schedule; Drug Combinations; Drug Resistance, Multiple; Drug Therapy, Combination; Female; Follow-Up Studies; Gentamicins; Humans; Imipenem; Infant, Newborn; Injections, Intravenous; Male; Pregnancy; Pregnancy Complications, Infectious; Proteus; Proteus Infections; Puerperal Infection; Treatment Outcome | 1998 |
Molecular characterization of epidemic multiresistant Staphylococcus haemolyticus isolates.
Topics: Ampicillin; Anti-Bacterial Agents; Cefazolin; Cefmetazole; Cross Infection; DNA Restriction Enzymes; Drug Resistance, Microbial; Drug Resistance, Multiple; Electrophoresis, Gel, Pulsed-Field; Gentamicins; Hospital Bed Capacity, 500 and over; Humans; Imipenem; Infant, Newborn; Microbial Sensitivity Tests; Neonatal Nursing; Nursing Staff, Hospital; Ofloxacin; Oxacillin; Phylogeny; Staphylococcal Infections; Staphylococcus; Tobramycin; Vancomycin | 1998 |
[Effects of isepamicin and beta-lactam antibiotics on the release of endotoxin from Pseudomonas aeruginosa].
Topics: Anti-Bacterial Agents; Ceftazidime; Cephalosporins; Endotoxins; Gentamicins; Imipenem; Penicillins; Piperacillin; Pseudomonas aeruginosa; Thienamycins | 1999 |
[The resistance of recent clinical isolates against isepamycin, other aminoglycosides and injectable beta-lactams].
Topics: Amikacin; Anti-Bacterial Agents; Bacteria; Ceftazidime; Dibekacin; Drug Resistance, Microbial; Gentamicins; Humans; Imipenem; Piperacillin; Tobramycin | 2000 |
[In vitro interaction of piperacillin and imipenem/cilastatin combined with aminoglycosides against Pseudomonas aeruginosa].
Topics: Amikacin; Anti-Bacterial Agents; Cilastatin; Cilastatin, Imipenem Drug Combination; Drug Combinations; Drug Resistance, Microbial; Drug Synergism; Drug Therapy, Combination; Gentamicins; Imipenem; Netilmicin; Penicillins; Piperacillin; Pseudomonas aeruginosa; Tobramycin | 2000 |
Splenic abscesses caused by Actinomyces meyeri in a patient with autoimmune hepatitis.
Topics: Abdominal Abscess; Actinomycosis; Adolescent; Boutonneuse Fever; Diagnosis, Differential; Endocarditis, Bacterial; Female; Gentamicins; Hepatitis, Autoimmune; Humans; Imipenem; Spleen; Vancomycin | 2000 |
[Impediment of cellular immune response under treatment with ticlopidine in a patient with Staphylococcus aureus endocarditis].
Topics: Agranulocytosis; Angioplasty, Balloon, Coronary; Anti-Bacterial Agents; Clarithromycin; Coronary Disease; Drug Therapy, Combination; Echocardiography, Doppler; Endocarditis, Bacterial; Fibrinolytic Agents; Gentamicins; Humans; Imipenem; Immunity, Cellular; Leukocyte Count; Leukocytes; Leukopenia; Male; Middle Aged; Platelet Aggregation Inhibitors; Staphylococcal Infections; Thienamycins; Ticlopidine; Time Factors; Vancomycin | 2000 |
The immunomodulatory effects of gentamicin, imipenem, piperacillin and amphotericin B on LAK effector function in vitro.
Topics: Adjuvants, Immunologic; Amphotericin B; Anti-Bacterial Agents; Bone Marrow Transplantation; Cell Line; Cytotoxicity Tests, Immunologic; Gentamicins; Humans; Imipenem; Killer Cells, Lymphokine-Activated; Penicillins; Piperacillin; Thienamycins | 2001 |
[Medical treatment of infected pancreatic necrosis].
Topics: Aged; Ciprofloxacin; Combined Modality Therapy; Drug Therapy, Combination; Gentamicins; Humans; Imipenem; Klebsiella Infections; Klebsiella pneumoniae; Male; Pancreatitis, Acute Necrotizing; Parenteral Nutrition, Total; Trimethoprim, Sulfamethoxazole Drug Combination | 2001 |
Microbiology of choledochal bile in patients with choledocholithiasis admitted to a tertiary hospital.
Topics: Adult; Aged; Aged, 80 and over; Ampicillin; Anti-Bacterial Agents; Brazil; Cephalosporins; Cholangiopancreatography, Endoscopic Retrograde; Common Bile Duct; Disease Susceptibility; Female; Gallstones; Gentamicins; Gram-Negative Bacterial Infections; Gram-Positive Bacterial Infections; Humans; Imipenem; Male; Microbial Sensitivity Tests; Middle Aged; Patient Admission; Penicillins; Treatment Outcome | 2003 |
[A man with Campylobacter endocarditis, treatable as Campylobacter fetus following identification].
Topics: Abattoirs; Animals; Anti-Bacterial Agents; Campylobacter fetus; Campylobacter Infections; Endocarditis, Bacterial; Gentamicins; Humans; Imipenem; Male; Microbial Sensitivity Tests; Middle Aged; Occupational Diseases; Wounds, Stab; Zoonoses | 2003 |
Antibiotics improve survival and alter the inflammatory profile in a murine model of sepsis from Pseudomonas aeruginosa pneumonia.
Topics: Animals; Anti-Bacterial Agents; Biomarkers; Cytokines; Disease Models, Animal; Gentamicins; Imipenem; Interleukin-6; Lipopolysaccharides; Mice; Mice, Inbred Strains; Pneumonia, Bacterial; Pseudomonas aeruginosa; Pseudomonas Infections; Sepsis; Survival Analysis; Time Factors | 2003 |
Metallo-beta-lactamase producing Pseudomonas aeruginosa in a hospital from a rural area.
Topics: Amikacin; beta-Lactamases; Ceftazidime; Ceftriaxone; Chloramphenicol; Ciprofloxacin; Drug Resistance, Bacterial; Gentamicins; Hospitals, Rural; Imipenem; India; Pseudomonas aeruginosa; Species Specificity | 2005 |
In vitro activity of fosfomycin-gentamicin, fosfomycin-ceftazidime, fosfomycin-imipenem and ceftazidime-gentamicin combinations against ceftazidime-resistant Pseudomonas aeruginosa.
Topics: Anti-Bacterial Agents; Ceftazidime; Drug Resistance, Bacterial; Drug Therapy, Combination; Fosfomycin; Gentamicins; Humans; Imipenem; In Vitro Techniques; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Thailand | 2005 |
[Comparative studies on activities of antimicrobial agents against causative organisms isolated from patients with urinary tract infections (2004). I. Susceptibility distribution].
Topics: Aminoglycosides; Ampicillin; Anti-Infective Agents; Aztreonam; Cefixime; Cefozopran; Cefpirome; Cefpodoxime; Ceftizoxime; Cephalosporins; Dibekacin; Drug Resistance, Bacterial; Enterococcus faecalis; Escherichia coli; Gentamicins; Gram-Negative Bacteria; Gram-Positive Bacteria; Humans; Imipenem; Klebsiella pneumoniae; Meropenem; Microbial Sensitivity Tests; Proteus mirabilis; Pseudomonas aeruginosa; Quinolones; Serratia marcescens; Staphylococcus aureus; Thienamycins; Urinary Tract Infections; Vancomycin | 2006 |
Antibiotic-resistance patterns and frequency of extended-spectrum beta-lactamase-producing isolates of Klebsiella pneumoniae in Tehran.
Topics: Anti-Infective Agents; beta-Lactamases; Cefepime; Cephalosporins; Ciprofloxacin; Drug Evaluation, Preclinical; Drug Resistance, Bacterial; Female; Gentamicins; Humans; Imipenem; Iran; Klebsiella pneumoniae; Male; Meropenem; Thienamycins | 2006 |
[Comparative study of treatment with quinupristin-dalfopristin alone or in combination with gentamicin, teicoplanin, imipenem or levofloxacin in experimental endocarditis due to a multidrug-resistant Enterococcus faecium].
Topics: Aged; Animals; Anti-Bacterial Agents; Disease Models, Animal; Drug Resistance, Multiple, Bacterial; Drug Therapy, Combination; Endocarditis, Bacterial; Enterococcus faecium; Female; Gentamicins; Gram-Positive Bacterial Infections; Humans; Imipenem; Levofloxacin; Microbial Sensitivity Tests; Ofloxacin; Rabbits; Teicoplanin; Virginiamycin | 2006 |
Biocompatability of hydroxyapatite composite as a local drug delivery system.
Topics: Amphotericin B; Biocompatible Materials; Calcium Sulfate; Chitosan; Drug Delivery Systems; Durapatite; Fosfomycin; Gentamicins; Humans; Imipenem; Osteoblasts | 2006 |
[Escherichia coli endocarditis: a report of two cases].
Topics: Aged; Anti-Bacterial Agents; Bacteremia; Ceftriaxone; Combined Modality Therapy; Endocarditis, Bacterial; Escherichia coli Infections; Female; Gastroenteritis; Gentamicins; Heart Valve Prosthesis Implantation; Humans; Imipenem; Middle Aged; Urinary Tract Infections | 2007 |
Molecular epidemiology and characterization of resistance mechanisms to various antimicrobial agents in Acinetobacter baumannii isolated in Mérida, Venezuela.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Adult; Anti-Bacterial Agents; beta-Lactamases; Cefepime; Cephalosporins; Ciprofloxacin; Disease Outbreaks; DNA Primers; Drug Resistance, Multiple, Bacterial; Electrophoresis, Gel, Pulsed-Field; Genes, Bacterial; Gentamicins; Humans; Imipenem; Infant, Newborn; Tetracyclines; Venezuela | 2007 |
Ertapenem resistance of Escherichia coli.
Topics: Anti-Bacterial Agents; Antifungal Agents; beta-Lactams; Cilastatin; Cilastatin, Imipenem Drug Combination; Drug Combinations; Drug Resistance, Multiple, Bacterial; Ertapenem; Escherichia coli; Escherichia coli Infections; Female; Fluconazole; Gentamicins; Humans; Imipenem; Immunocompromised Host; Middle Aged; Vancomycin | 2007 |
[Antibmicrobial susceptibility of Serratia marcescens isolated from hospitalized patients in 2003 - 2005].
Topics: Amikacin; Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactamases; Ciprofloxacin; Cross Infection; Disk Diffusion Antimicrobial Tests; Drug Resistance, Multiple, Bacterial; Gentamicins; Humans; Imipenem; Meropenem; Microbial Sensitivity Tests; Poland; Serratia marcescens; Thienamycins | 2007 |
Research and clinical value of antibacterial-application software.
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Cefepime; Cephalosporins; Enterobacter cloacae; Enterobacteriaceae Infections; Female; Gentamicins; Humans; Imipenem; Isosorbide Dinitrate; Male; Ofloxacin; Software | 2008 |
In vitro activity of cefepime, imipenem, tigecycline, and gentamicin, alone and in combination, against extended-spectrum beta-lactamase-producing Klebsiella pneumoniae and Escherichia coli.
Topics: Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactamases; Cefepime; Cephalosporins; Drug Therapy, Combination; Escherichia coli; Gentamicins; Imipenem; Klebsiella pneumoniae; Microbial Sensitivity Tests; Minocycline; Tigecycline | 2008 |
Phosphorylcholine impairs susceptibility to biofilm formation of hydrogel contact lenses.
Topics: Anti-Bacterial Agents; Bacterial Adhesion; Biofilms; Coated Materials, Biocompatible; Contact Lenses, Hydrophilic; Gentamicins; Hydrogel, Polyethylene Glycol Dimethacrylate; Imipenem; Microbial Sensitivity Tests; Microscopy, Confocal; Penicillanic Acid; Phosphorylcholine; Piperacillin; Piperacillin, Tazobactam Drug Combination; Polyhydroxyethyl Methacrylate; Pseudomonas aeruginosa; Silicon; Staphylococcus epidermidis | 2009 |
[Pseudomonas aeruginosa bacteremia: associations with a source of infection and antibiotic resistance].
Topics: Amikacin; Anti-Bacterial Agents; Bacteremia; Bacteriological Techniques; Ceftazidime; Ciprofloxacin; Drug Resistance, Bacterial; Drug Resistance, Multiple, Bacterial; Gentamicins; Humans; Imipenem; Meropenem; Microbial Sensitivity Tests; Piperacillin; Pseudomonas aeruginosa; Pseudomonas Infections; Respiratory Tract Infections; Retrospective Studies; Thienamycins; Wound Infection | 2009 |
[Antimicrobial resistance of clinical isolates of Stenotrophomonas maltophilia].
Topics: Amikacin; Drug Resistance, Multiple, Bacterial; Gentamicins; Humans; Imipenem; Microbial Sensitivity Tests; Stenotrophomonas maltophilia | 2009 |
Effect of subinhibitory concentrations of antibiotics on intrachromosomal homologous recombination in Escherichia coli.
Topics: Ampicillin; Anti-Bacterial Agents; Ceftazidime; Chloramphenicol; Chromosomes, Bacterial; Ciprofloxacin; Colistin; Escherichia coli; Fosfomycin; Gentamicins; Imipenem; Microbial Sensitivity Tests; Recombination, Genetic; Rifampin; Tetracycline; Trimethoprim | 2009 |
Detection of the novel extended-spectrum beta-lactamase OXA-161 from a plasmid-located integron in Pseudomonas aeruginosa clinical isolates from Spain.
Topics: Amikacin; Aminoglycosides; Anti-Bacterial Agents; beta-Lactamases; Cefepime; Cephalosporins; Clavulanic Acid; Gentamicins; Humans; Imipenem; Integrons; Meropenem; Molecular Sequence Data; Penicillanic Acid; Piperacillin; Plasmids; Pseudomonas aeruginosa; Pseudomonas Infections; Spain; Tazobactam; Thienamycins | 2009 |
Chronic suppurative otitis media in cleft palate: microorganism etiology and susceptibilities.
Topics: Adolescent; Adult; Anti-Bacterial Agents; Bacteria; Child; Child, Preschool; Chronic Disease; Ciprofloxacin; Cleft Lip; Cleft Palate; Drug Resistance, Bacterial; Enterococcus faecalis; Female; Gentamicins; Gram-Positive Bacterial Infections; Humans; Imipenem; Infant; Male; Middle Aged; Otitis Media, Suppurative; Proteus Infections; Proteus mirabilis; Pseudomonas aeruginosa; Pseudomonas Infections; Staphylococcal Infections; Staphylococcus aureus; Trimethoprim, Sulfamethoxazole Drug Combination; Young Adult | 2009 |
Outbreaks of imipenem resistant Acinetobacter baumannii producing OXA-23 beta-lactamase in a tertiary care hospital in Korea.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; beta-Lactamases; beta-Lactams; Cefepime; Cephalosporins; Ciprofloxacin; Disease Outbreaks; Drug Resistance, Multiple, Bacterial; Electrophoresis, Gel, Pulsed-Field; Gentamicins; Humans; Imipenem; Korea; Microbial Sensitivity Tests | 2009 |
In vitro antimicrobials activity against endemic Acinetobacter baumannii multiresistant clones.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; Argentina; beta-Lactamases; Colistin; Drug Resistance, Multiple, Bacterial; Drug Synergism; Drug Therapy, Combination; Endemic Diseases; Gentamicins; Humans; Imipenem; Microbial Sensitivity Tests; Rifampin | 2010 |
[Two cases of pulmonary gangrene in HIV-infected patients: favorable outcome without surgery].
Topics: Acetamides; Adult; Alcoholism; Amoxicillin; Anti-Bacterial Agents; Drug Therapy, Combination; Gangrene; Gentamicins; HIV Infections; Humans; Imipenem; Linezolid; Lung; Male; Metronidazole; Necrosis; Ofloxacin; Oxazolidinones; Pneumonia, Bacterial; Pneumonia, Pneumococcal; Smoking; Tomography, X-Ray Computed | 2011 |
Antibiotics cure anthrax in animal models.
Topics: Animals; Anthrax; Anthrax Vaccines; Anti-Bacterial Agents; Antigens, Bacterial; Bacillus anthracis; Bacteremia; Doxycycline; Enzyme-Linked Immunosorbent Assay; Gentamicins; Guinea Pigs; Imipenem; Ofloxacin; Rabbits | 2011 |
Risk factors for bacteraemia attributable to Pseudomonas aeruginosa resistant to imipenem, levofloxacin, or gentamicin.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacteremia; Child; Child, Preschool; Drug Resistance, Multiple, Bacterial; Female; Gentamicins; Humans; Imipenem; Infant; Infant, Newborn; Levofloxacin; Male; Middle Aged; Ofloxacin; Pseudomonas aeruginosa; Pseudomonas Infections; Risk Factors; Young Adult | 2011 |
Bactericidal effects of antimicrobial agents on epithelial cell-associated Pseudomonas aeruginosa.
Topics: Animals; Anti-Bacterial Agents; Cell Line, Transformed; Cell Line, Tumor; Ciprofloxacin; Dogs; Epithelial Cells; Gentamicins; Humans; Imipenem; Madin Darby Canine Kidney Cells; Microbial Sensitivity Tests; Pseudomonas aeruginosa | 2012 |
Antibiotic selection for the treatment of infectious complications of implant-based breast reconstruction.
Topics: Administration, Oral; Adult; Aged; Anti-Bacterial Agents; Breast Implantation; Breast Implants; Device Removal; Drainage; Drug Resistance, Bacterial; Female; Fluoroquinolones; Free Tissue Flaps; Gentamicins; Gram-Negative Bacterial Infections; Gram-Positive Bacterial Infections; Humans; Imipenem; Injections, Intravenous; Microbial Sensitivity Tests; Middle Aged; Radiography, Interventional; Reoperation; Retrospective Studies; Surgical Wound Infection; Tissue Expansion Devices; Treatment Outcome; Vancomycin | 2013 |
Comparative activities of telavancin combined with nafcillin, imipenem, and gentamicin against Staphylococcus aureus.
Topics: Aminoglycosides; Anti-Bacterial Agents; Drug Synergism; Drug Therapy, Combination; Gentamicins; Humans; Imipenem; Lipoglycopeptides; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Models, Biological; Nafcillin; Staphylococcal Infections; Staphylococcus aureus; Vancomycin Resistance | 2013 |
Methicillin-resistant coagulase-negative staphylococci (MRCoNS) by disk diffusion method.
Topics: Anti-Bacterial Agents; Ceftriaxone; Cefuroxime; Ciprofloxacin; Coagulase; Drug Resistance, Multiple, Bacterial; Exudates and Transudates; Gentamicins; Humans; Imipenem; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Oxacillin; Staphylococcal Infections; Suppuration; Surgical Wound Infection; Vancomycin | 2013 |
Effects of subinhibitory concentrations of antimicrobial agents on Escherichia coli O157:H7 Shiga toxin release and role of the SOS response.
Topics: Anti-Infective Agents; Azithromycin; DNA, Bacterial; Escherichia coli O157; Gene Expression Regulation, Bacterial; Genes, Bacterial; Gentamicins; Humans; Imipenem; Latex Fixation Tests; Microbial Sensitivity Tests; Norfloxacin; Prophages; Real-Time Polymerase Chain Reaction; Rifampin; Shiga Toxin; SOS Response, Genetics | 2013 |
Meningitis and endocarditis caused by Campylobacter fetus after raw-liver ingestion.
Topics: Administration, Intravenous; Aged; Anti-Bacterial Agents; Blood; Campylobacter fetus; Cerebrospinal Fluid; Drug Therapy, Combination; Endocarditis, Bacterial; Feeding Behavior; Foodborne Diseases; Gentamicins; Humans; Imipenem; Male; Meningitis, Bacterial; Treatment Outcome | 2013 |
A comparative study of clinical Aeromonas dhakensis and Aeromonas hydrophila isolates in southern Taiwan: A. dhakensis is more predominant and virulent.
Topics: Adult; Aeromonas; Aged; Animals; Anti-Bacterial Agents; Biofilms; Caenorhabditis elegans; Ceftriaxone; Cell Survival; DNA Gyrase; DNA-Directed RNA Polymerases; Female; Fibroblasts; Gentamicins; Gram-Negative Bacterial Infections; Humans; Imipenem; Male; Microbial Sensitivity Tests; Middle Aged; Molecular Sequence Data; Prevalence; Sequence Analysis, DNA; Soft Tissue Infections; Survival Analysis; Taiwan; Wound Infection | 2014 |
Multidrug and extensive drug resistance in Pseudomonas aeruginosa clinical isolates from a Portuguese central hospital: 10-year survey.
Topics: Adolescent; Adult; Aged; Anti-Bacterial Agents; Cross Infection; Drug Resistance, Multiple, Bacterial; Female; Gentamicins; Hospitals; Humans; Imipenem; Male; Middle Aged; Pseudomonas aeruginosa; Pseudomonas Infections; Young Adult | 2015 |
Right-sided infective endocarditis with a ruptured sinus of Valsalva and multiple septic pulmonary emboli in a patient with atopic dermatitis.
Topics: Adult; Anti-Infective Agents; Cilastatin; Cilastatin, Imipenem Drug Combination; Dermatitis, Atopic; Drug Combinations; Endocarditis, Bacterial; Female; Gentamicins; Heart Failure; Humans; Imipenem; Methicillin-Resistant Staphylococcus aureus; Sinus of Valsalva; Treatment Outcome; Tricuspid Valve | 2015 |
Endothelial Cell Toxicity of Vancomycin Infusion Combined with Other Antibiotics.
Topics: Anti-Bacterial Agents; Cell Death; Cells, Cultured; Cilastatin; Cilastatin, Imipenem Drug Combination; Drug Combinations; Drug Therapy, Combination; Erythromycin; Gentamicins; Human Umbilical Vein Endothelial Cells; Humans; Imipenem; Infusions, Intravenous; Vancomycin | 2015 |
Silver- and fluoride-containing mesoporous bioactive glasses versus commonly used antibiotics: Activity against multidrug-resistant bacterial strains isolated from patients with burns.
Topics: Amikacin; Animals; Anti-Bacterial Agents; Aztreonam; Burns; Carbenicillin; Cefepime; Ceftazidime; Ceftriaxone; Cell Survival; Cephalosporins; Ciprofloxacin; Drug Resistance, Multiple, Bacterial; Fluorides; Gentamicins; Glass; Humans; Imipenem; Meropenem; Mice; Microbial Sensitivity Tests; NIH 3T3 Cells; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Pseudomonas aeruginosa; Silver; Thienamycins; Tobramycin; Wound Infection | 2016 |
[The comparison of antibiotic susceptibilities of uropathogenic Escherichia coli isolates in transition from CLSI to EUCAST].
Topics: Amikacin; Ampicillin; Anti-Bacterial Agents; Bacteriuria; Cefuroxime; Ciprofloxacin; Disk Diffusion Antimicrobial Tests; Drug Resistance, Bacterial; Escherichia coli Infections; European Union; Gentamicins; Humans; Imipenem; Levofloxacin; Microbial Sensitivity Tests; Reference Standards; Sulbactam; Trimethoprim, Sulfamethoxazole Drug Combination; Turkey; Urinary Tract Infections; Uropathogenic Escherichia coli | 2015 |
In Vivo and In Vitro Efficacy of Minocycline-Based Combination Therapy for Minocycline-Resistant Acinetobacter baumannii.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Animals; Anti-Bacterial Agents; Biofilms; Cefepime; Cephalosporins; Colistin; Drug Resistance, Multiple, Bacterial; Gentamicins; Imipenem; Meropenem; Mice; Microbial Sensitivity Tests; Minocycline; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Pneumonia; Taiwan; Thienamycins | 2016 |
Phenotypic and genetic changes in the life cycle of small colony variants of Salmonella enterica serotype Typhimurium induced by streptomycin.
Topics: Amino Acid Sequence; Anti-Bacterial Agents; Bacterial Proteins; Biofilms; Frameshift Mutation; Gene Expression Regulation, Bacterial; Genetic Variation; Genome, Bacterial; Gentamicins; High-Throughput Nucleotide Sequencing; Imipenem; Methyltransferases; Microbial Sensitivity Tests; Peptide Termination Factors; Phenotype; Salmonella typhimurium; Streptomycin | 2016 |
Successful Treatment of Urinary Tract Infection in Kidney Transplant Recipients Caused by Multiresistant Klebsiella pneumoniae Producing New Delhi Metallo-Beta-Lactamase (NDM-1) With Strains Genotyping.
Topics: Anti-Bacterial Agents; beta-Lactamases; Cilastatin; Cilastatin, Imipenem Drug Combination; Colistin; Drug Combinations; Drug Resistance, Microbial; Electrophoresis, Gel, Pulsed-Field; Fosfomycin; Genotype; Gentamicins; Humans; Imipenem; Kidney Transplantation; Klebsiella Infections; Klebsiella pneumoniae; Male; Microbial Sensitivity Tests; Transplant Recipients; Trimethoprim, Sulfamethoxazole Drug Combination; Urinary Tract Infections | 2016 |
Correlation between antimicrobial consumption and antimicrobial resistance of Pseudomonas aeruginosa in a hospital setting: a 10-year study.
Topics: Amikacin; Anti-Bacterial Agents; Anti-Infective Agents; beta-Lactams; Carbapenems; Drug Resistance, Bacterial; Drug Utilization; Gentamicins; Hospitals; Humans; Imipenem; Meropenem; Pseudomonas aeruginosa; Serbia; Thienamycins | 2016 |
Empiric antibiotic protocols for cancer patients with neutropenia: a single-center study of treatment efficacy and mortality in patients with bacteremia.
Topics: Adult; Anti-Bacterial Agents; Bacteremia; Blood Culture; Carbapenem-Resistant Enterobacteriaceae; Cefazolin; Clinical Protocols; Enterobacteriaceae Infections; Gentamicins; Humans; Imipenem; Microbial Sensitivity Tests; Middle Aged; Neoplasms; Neutropenia; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Pseudomonas aeruginosa; Pseudomonas Infections; Retrospective Studies; Staphylococcal Infections; Staphylococcus aureus; Streptococcal Infections; Streptococcus | 2018 |
In vitro interaction of ceftazidime-avibactam in combination with different antimicrobials against KPC-producing Klebsiella pneumoniae clinical isolates.
Topics: Anti-Bacterial Agents; Azabicyclo Compounds; beta-Lactamase Inhibitors; beta-Lactams; Ceftazidime; Cephalosporins; Drug Combinations; Ertapenem; Gentamicins; Humans; Imipenem; Italy; Klebsiella pneumoniae; Meropenem; Microbial Sensitivity Tests; Minocycline; Thienamycins; Tigecycline | 2017 |
Collateral sensitivity between aminoglycosides and beta-lactam antibiotics depends on active proton pumps.
Topics: Aminoglycosides; Anti-Bacterial Agents; Bacterial Outer Membrane Proteins; Bacterial Proteins; beta-Lactams; Burns; Cross-Sectional Studies; Drug Resistance, Multiple, Bacterial; Gene Expression Regulation, Bacterial; Genes, Bacterial; Genes, MDR; Gentamicins; Humans; Imipenem; Iran; Membrane Transport Proteins; Microbial Sensitivity Tests; Polymerase Chain Reaction; Proton Pumps; Pseudomonas aeruginosa; Pseudomonas Infections | 2017 |
Prevention of High-Level Daptomycin-Resistance Emergence In Vitro in Streptococcus mitis-oralis by Using Combination Antimicrobial Strategies.
Topics: Anti-Bacterial Agents; Ceftaroline; Cephalosporins; Daptomycin; Drug Combinations; Drug Resistance, Bacterial; Gentamicins; Humans; Imipenem; Linezolid; Microbial Sensitivity Tests; Organophosphates; Oxazoles; Rifampin; Streptococcus mitis; Streptococcus oralis; Trimethoprim, Sulfamethoxazole Drug Combination | 2018 |
Multidrug resistance, prevalence and phylogenetic analysis of genes encoding class II and III integrons in clinically isolated Escherichia coli.
Topics: Amikacin; Ampicillin; Anti-Bacterial Agents; Base Sequence; Cefotaxime; Ciprofloxacin; Drug Resistance, Multiple, Bacterial; Escherichia coli; Escherichia coli Infections; Gene Expression Regulation, Bacterial; Gentamicins; Hospitals; Humans; Imipenem; Integrons; Microbial Sensitivity Tests; Nalidixic Acid; Ofloxacin; Phylogeny; Polymerase Chain Reaction; Prevalence; Saudi Arabia; Sequence Alignment | 2018 |
New roles of fluoxetine in pharmacology: Antibacterial effect and modulation of antibiotic activity.
Topics: Anti-Bacterial Agents; Antidepressive Agents; Bacteria; Drug Combinations; Drug Synergism; Erythromycin; Escherichia coli; Fluoxetine; Gentamicins; Imipenem; Microbial Sensitivity Tests; Norfloxacin; Pseudomonas aeruginosa; Staphylococcus aureus; Tetracycline | 2018 |
Imipenem toxicity in male reproductive organs as a result of inflammatory microenvironment and oxidative stress in germinal cells.
Topics: Animals; Anti-Bacterial Agents; Apoptosis; Cellular Microenvironment; Epididymis; Gentamicins; Imipenem; Infertility, Male; Inflammation Mediators; Lipid Peroxidation; Male; Oxidative Stress; Protein Carbonylation; Rats, Wistar; Signal Transduction; Spermatogenesis; Spermatozoa; Testis; Testosterone | 2019 |
Antibiotic susceptibility of cultivable aerobic microbiota from the oral cavity of Echis carinatus from Odisha (India).
Topics: Ampicillin; Animals; Anti-Bacterial Agents; Azithromycin; Cefpodoxime; Ceftizoxime; Ciprofloxacin; Gentamicins; Imipenem; Methicillin; Microbial Sensitivity Tests; Microbiota; Mouth; Penicillins; Phylogeny; RNA, Ribosomal, 16S; Viperidae | 2020 |
Antibiogram and molecular characterization of multi-drug resistant microorganisms isolated from urinary tract infections.
Topics: Amikacin; Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Ciprofloxacin; Drug Resistance, Multiple, Bacterial; Escherichia coli; Escherichia coli Infections; Gentamicins; Humans; Imipenem; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests; Nitrofurantoin; Oxacillin; Pakistan; Pipemidic Acid; Piperacillin, Tazobactam Drug Combination; Polymyxin B; Pseudomonas aeruginosa; Pseudomonas Infections; Trimethoprim, Sulfamethoxazole Drug Combination; Urinary Tract Infections | 2021 |
Machine learning for identifying resistance features of
Topics: Amikacin; Anti-Bacterial Agents; Cross Infection; Drug Resistance, Multiple, Bacterial; Genome, Bacterial; Gentamicins; Humans; Imipenem; Klebsiella Infections; Klebsiella pneumoniae; Machine Learning; Microbial Sensitivity Tests; Polymorphism, Single Nucleotide; Tetracyclines | 2021 |
Microbial spectrum and drug resistance profile in solid malignancies in a large tertiary hospital from Palestine.
Topics: Ampicillin; Anti-Bacterial Agents; Drug Resistance; Drug Resistance, Bacterial; Escherichia coli; Female; Gentamicins; Gram-Negative Bacteria; Humans; Imipenem; Male; Meropenem; Microbial Sensitivity Tests; Middle Aged; Neoplasms; Retrospective Studies; Staphylococcus; Tertiary Care Centers | 2022 |
Hemoperfusion with Seraph 100 Microbind Affinity Blood Filter Unlikely to Require Increased Antibiotic Dosing: A Simulations Study Using a Pharmacokinetic/Pharmacodynamic Approach.
Topics: Anti-Bacterial Agents; Critical Illness; Gentamicins; Hemoperfusion; Humans; Imipenem; Meropenem; Vancomycin | 2023 |
Antimicrobial resistance, virulence factors, and genotypes of Pseudomonas aeruginosa clinical isolates from Gorgan, northern Iran.
Topics: Amikacin; Anti-Bacterial Agents; Ceftazidime; Ciprofloxacin; Colistin; Deoxyribonucleases; Drug Resistance, Bacterial; Genotype; Gentamicins; Humans; Imipenem; Iran; Levofloxacin; Meropenem; Microbial Sensitivity Tests; Pancreatic Elastase; Phospholipases; Piperacillin; Piperacillin, Tazobactam Drug Combination; Polymyxin B; Pseudomonas aeruginosa; Pseudomonas Infections; Tobramycin; Virulence Factors | 2022 |
The prevalence of multiple drug resistance Escherichia coli and Klebsiella pneumoniae isolated from patients with urinary tract infections.
Topics: Ampicillin; Anti-Bacterial Agents; Aztreonam; Cefepime; Ceftazidime; Ceftriaxone; Ciprofloxacin; Drug Resistance, Multiple; Escherichia coli; Escherichia coli Infections; Gentamicins; Humans; Imipenem; Klebsiella Infections; Klebsiella pneumoniae; Levofloxacin; Microbial Sensitivity Tests; Piperacillin; Prevalence; Trimethoprim, Sulfamethoxazole Drug Combination; Urinary Tract Infections | 2022 |
Antibiotic resistance's Genotypic and Phenotypic Characteristics and the Frequency of Virulence Factors in
Topics: Anti-Bacterial Agents; Chloramphenicol; Drinking Water; Enrofloxacin; Erythromycin; Gentamicins; Humans; Imipenem; Iran; Meropenem; Microbial Sensitivity Tests; Mineral Waters; Pseudomonas aeruginosa; Pseudomonas Infections; Virulence Factors | 2022 |
Genotypic Detection of
Topics: Agar; Amikacin; Anti-Bacterial Agents; Ceftazidime; Ceftriaxone; Ciprofloxacin; Citrobacter koseri; Gentamicins; Humans; Imipenem; Levofloxacin; Microbial Sensitivity Tests; Urinary Tract Infections | 2022 |
Ciprofloxacin resistance and tolerance of Pseudomonas aeruginosa ocular isolates.
Topics: Agar; Anti-Bacterial Agents; Ceftazidime; Ciprofloxacin; Gentamicins; Humans; Imipenem; Keratitis; Levofloxacin; Microbial Sensitivity Tests; Piperacillin; Polymyxin B; Pseudomonas aeruginosa; Pseudomonas Infections; Tobramycin | 2023 |
Molecular identification and antimicrobial resistance pattern of Nocardia isolated from 14 diseased dogs and cats.
Topics: Animals; Anti-Bacterial Agents; Anti-Infective Agents; Cat Diseases; Cats; Cefuroxime; Dog Diseases; Dogs; Drug Resistance, Bacterial; Gentamicins; Humans; Imipenem; Microbial Sensitivity Tests; Nocardia; Nocardia Infections; Osteomyelitis; RNA, Ribosomal, 16S | 2023 |
Translation of Machine Learning-Based Prediction Algorithms to Personalised Empiric Antibiotic Selection: A Population-Based Cohort Study.
Topics: Aged; Algorithms; Ampicillin; Anti-Bacterial Agents; Cefepime; Ciprofloxacin; Cohort Studies; Female; Gentamicins; Humans; Imipenem; Machine Learning; Male; Middle Aged; Sulbactam; Sulfamethoxazole; Trimethoprim; Urinary Tract Infections | 2023 |
Bacteriological Profile and Drug Susceptibility in Mucosal type Chronic Suppurative Otitis Media.
Topics: Amikacin; Anti-Bacterial Agents; Escherichia coli; Female; Gentamicins; Humans; Imipenem; Male; Nepal; Otitis Media, Suppurative; Staphylococcal Infections | 2023 |
Detection of Enterobacteriaceae in cerebrospinal fluid fluid of neonates with meningitis from tertiary care hospitals.
Topics: Amikacin; Anti-Bacterial Agents; Cefepime; Child; Ciprofloxacin; Drug Resistance, Bacterial; Enterobacteriaceae; Escherichia coli; Gentamicins; Gram-Negative Bacteria; Humans; Imipenem; Infant; Infant, Newborn; Meningitis, Bacterial; Microbial Sensitivity Tests; Tertiary Care Centers | 2023 |